Our partner CRISPR QC is actively using Cardea’s CRISPR-Chip Technology to provide insight into key parameters of editing efficiency. Their assays can determine how well a gRNA is binding to a Cas enzyme, and how well a gRNA + Cas complex is binding to its intended target. This insight allows researchers to select only the best guides and Cas enzymes for their editing experiments – saving significant time and resources that would have otherwise been wasted on using ineffective reagents.
Run rapid assessments of gRNA - CAS interactions
Optimize CRISPR designs
Identify specificity, performance, and the most optimal conditions to select the most robust guide